Ross Dunn

发表

Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.

C. O. Kamlin, J. Cheong, P. Dargaville, 2023, JAMA.

Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.

J. Carlin, C. O. Kamlin, P. Davis, 2021, JAMA.